Literature DB >> 19523328

Mesenchymal stem cell therapy for nonmusculoskeletal diseases: emerging applications.

Tom K Kuo1, Jennifer H Ho, Oscar K Lee.   

Abstract

Mesenchymal stem cells are stem/progenitor cells originated from the mesoderm and can different into multiple cell types of the musculoskeletal system. The vast differentiation potential and the relative ease for culture expansion have established mesenchymal stem cells as the building blocks in cell therapy and tissue engineering applications for a variety of musculoskeletal diseases, including repair of fractures and bone defects, cartilage regeneration, treatment of osteonecrosis of the femoral head, and correction of genetic diseases such as osteogenesis imperfect. However, research in the past decade has revealed differentiation potentials of mesenchymal stem cells beyond lineages of the mesoderm, suggesting broader applications than originally perceived. In this article, we review the recent developments in mesenchymal stem cell research with respect to their emerging properties and applications in nonmusculoskeletal diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19523328     DOI: 10.3727/096368909X471206

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  17 in total

Review 1.  Therapeutic application of mesenchymal stem cells in bone and joint diseases.

Authors:  Yi Liu; Jianmei Wu; Youming Zhu; Jinxiang Han
Journal:  Clin Exp Med       Date:  2012-11-03       Impact factor: 3.984

Review 2.  Tendon-derived stem cells (TDSCs): from basic science to potential roles in tendon pathology and tissue engineering applications.

Authors:  Pauline Po Yee Lui; Kai Ming Chan
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

3.  In Vivo Growing of New Cell Colonies in a Portion of Bone Marrow: Potential Use for Indirect Cell Therapy.

Authors:  Ana Manzanedo; Fidel Rodriguez; Jose A Obeso; Manuel Rodriguez
Journal:  Cell Med       Date:  2010-11-05

Review 4.  Regenerative medicine and the gut.

Authors:  Johann Peterson; Pankaj J Pasricha
Journal:  Gastroenterology       Date:  2011-08-22       Impact factor: 22.682

Review 5.  Application of bone marrow mesenchymal stem cells to the treatment of osteonecrosis of the femoral head.

Authors:  Cheng Wang; Yu Wang; Hao-Ye Meng; Xue-Ling Yuan; Xiao-Long Xu; Ai-Yuan Wang; Quan-Yi Guo; Jiang Peng; Shi-Bi Lu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  Prevention of acute liver allograft rejection by IL-10-engineered mesenchymal stem cells.

Authors:  J Niu; W Yue; Y Song; Y Zhang; X Qi; Z Wang; B Liu; H Shen; X Hu
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

7.  Stem cell-based therapy for prevention of delayed fracture union: a randomized and prospective preliminary study.

Authors:  Meir Liebergall; Josh Schroeder; Rami Mosheiff; Zulma Gazit; Zilberman Yoram; Linda Rasooly; Anat Daskal; Amal Khoury; Yoram Weil; Shaul Beyth
Journal:  Mol Ther       Date:  2013-06-04       Impact factor: 11.454

Review 8.  Immune tolerance induction by integrating innate and adaptive immune regulators.

Authors:  Jun Suzuki; Camillo Ricordi; Zhibin Chen
Journal:  Cell Transplant       Date:  2009-11-16       Impact factor: 4.064

9.  Detection of osteogenic differentiation by differential mineralized matrix production in mesenchymal stromal cells by Raman spectroscopy.

Authors:  Pei-San Hung; Yi-Chun Kuo; He-Guei Chen; Hui-Hua Kenny Chiang; Oscar Kuang-Sheng Lee
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

10.  Human mesenchymal stem cells suppress the stretch-induced inflammatory miR-155 and cytokines in bronchial epithelial cells.

Authors:  Yi-Chun Kuo; Yi-Shuan Julie Li; Jing Zhou; Yu-Ru Vernon Shih; Marina Miller; David Broide; Oscar Kuang-Sheng Lee; Shu Chien
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.